Sfoglia per Autore
Mutational activation of N-and K-RAS oncogenes in plasma cell dyscrasia.
1993-01-01 Corradini P; Ladetto M; Voena C; Palumbo A; Inghirami G; Knowels DM; Boccadoro M; Pileri A
Mutational activation of N- and K-ras oncogenes in plasma cell dyscrasias.
1993-01-01 Corradini P; Ladetto M; Voena C; Palumbo A; Inghirami G; Knowles DM; Boccadoro M; Pileri A.
Mutational activation of N- and K-ras oncogenes in plasma cell dyscrasias.
1993-01-01 Corradini P; Ladetto M; Voena C; Palumbo A; Inghirami G; Knowles DM; Boccadoro M; Pileri A.
The mutation of N-ras oncogene does not involve myeloid and erythroid lineages in a case of multiple myeloma.
1993-01-01 CORRADINI P ;FERRERO D ;VOENA C ;LADETTO M ;BOCCADORO M ;PILERI A
Inactivation of tumor suppressor genes, p53 and Rb1, in plasma cell dyscrasias.
1994-01-01 Corradini P; Inghirami G; Astolfi M; Ladetto M; Voena C; Ballerini P; Gu W; Nilsson K; Knowles DM; Boccadoro M; et al.
Inactivation of tumor suppressor genes, p53 and Rb1, in plasma cell dyscrasias.
1994-01-01 CORRADINI P; INGHIRAMI G; ASTOLFI M; LADETTO M; VOENA C; BALLERINI P; GU W; NILSSON K; KNOWLES DM; BOCCADORO M; PILERI A; DALLA FAVERA R
N- and K-ras oncogenes in plasma cell dyscrasias.
1994-01-01 Corradini P; Ladetto M; Inghirami G; Boccadoro M; Pileri A.
N- and K-ras oncogenes in plasma cell dyscrasias.
1994-01-01 CORRADINI P ;LADETTO M ;INGHIRAMI G ;BOCCADORO M ;PILERI A
High-dose sequential chemoradiotherapy in multiple myeloma: residual tumor cells are detectable in bone marrow and peripheral blood cell harvests and after autografting.
1995-01-01 Corradini P; Voena C; Astolfi M; Ladetto M; Tarella C; Boccadoro M; Pileri A
REAL TIME QUANTITATIVE PCR SHOWS THAT PERIPHERAL BLOOD STEM CELL (PBPC) HARVESTS ARE SIGNIFICANTLY LESS CONTAMINATED THAN BONE MARROW (BM) IN MULTIPLE MYELOMA PATIENTS (MM)
1996-01-01 LADETTO M; SAMETTI POS; DONOVAN JW; ASTOLFI M; GIACCONE L; GIARETTA F; VOPATA F; BRINGHEN S; PALUMBO A; BRUNO B; PILERI A; GRIBBEN JG; BOCCADORO M
Clinical and molecular remission after allogeneic blood cell transplantation in a patient with mantle-cell lymphoma.
1996-01-01 Corradini P; Ladetto M; Astolfi M; Voena C; Tarella C; Bacigalupo A; Pileri A
Long-term molecular remission after conventional chemotherapy in a patient with Philadelphia-negative acute lymphoblastic leukemia.
1996-01-01 Ladetto M; Corradini P; Astolfi M; Campana S; Tarella C; Pileri A
Analysis of the immunoglobulin heavy-chain gene rearrangement providing molecular evidence of second lymphoma in a patient in apparent relapse after autotransplantation.
1997-01-01 Campana S; Corradini P; Astolfi M; Ladetto M; Cinque F; Novero D; Tarella C; Pileri A.
A novel nested-PCR strategy for the detection of rearranged immunoglobulin heavy-chain genes in B cell tumors.
1997-01-01 VOENA C; M. LADETTO; ASTOLFI M; PROVAN D; GRIBBEN JG; BOCCADORO M; PILERI A; CORRADINI P.
Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autografting.
1997-01-01 CORRADINI P; ASTOLFI M; CHERASCO C; M. LADETTO; VOENA C; CARACCIOLO D; PILERI A; TARELLA C.
Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cells.
1999-01-01 Corradini P; Voena C; Tarella C; Astolfi M; Ladetto M; Palumbo A; Van Lint MT; Bacigalupo A; Santoro A; Musso M; Majolino I; Boccadoro M; Pileri A
Clinical relevance of minimal residual disease monitoring in non-Hodgkin's lymphomas: a critical reappraisal of molecular strategies.
1999-01-01 CORRADINI P; M. LADETTO; PILERI A; TARELLA C.
Negative immunomagnetic ex vivo purging combined with high-dose chemotherapy with peripheral blood progenitor cell autograft in follicular lymphoma patients: evidence for long-term clinical and molecular remissions.
1999-01-01 TARELLA C; CORRADINI P; ASTOLFI M; BONDESAN P; CARACCIOLO D; CHERASCO C; M. LADETTO; GIARETTA F; RICCA I; VITOLO U; PILERI A; FERRERO D
MULTIPLE MYELOMA: DIFFERENT PHENOTYPIC CHARACTERISTICS ARE SHOWN BY PLASMA CELLS FROM LEUKAPHERESIS AND BONE MARROW
2000-01-01 Omedè P; Giaretta F; Palumbo A; Ladetto M; Bruno B; Gilestro M; Sirica S; Rus C; Bringhen S; Triolo S; Giaccone L; Boccadoro M
REAL TIME QUANTITATIVE PCR SHOWS THAT PERIPHERAK BLOOD STEM CELL (PBPC) HARVESTS ARE SIGNIFICANTILY LESS CONTAMINATED THAN BONE MARROW (BM) IN MULTIPLE MYELOMA PATIENTS (MM).
2000-01-01 Ladetto M; Omedè P; Sametti S; Donovan JW; Astolfi M; Giaccone L; Giaretta F; Volpato F; Bringhen S; Palumbo A; Bruno B; Pileri A; Gribben JG; Boccadoro M.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile